Taro Pharmaceutical Indus analyst ratings
Taro Pharmaceutical Indus analyst ratings
While ratings are subjective and will change, the latest Taro Pharmaceutical Indus (TARO) rating was a maintained with a price target of $73.00 to $54.00. The current price Taro Pharmaceutical Indus (TARO) is trading at is $34.33, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2022 | 57.3% | HC Wainwright & Co. | $73 → $54 | Maintains | Buy |
| 01/31/2022 | 112.64% | HC Wainwright & Co. | $75 → $73 | Maintains | Buy |
| 01/18/2022 | 118.47% | HC Wainwright & Co. | $82 → $75 | Maintains | Buy |
| 07/28/2021 | 138.86% | HC Wainwright & Co. | $80 → $82 | Maintains | Buy |
| 06/02/2021 | 133.03% | HC Wainwright & Co. | $81 → $80 | Maintains | Buy |
| 02/01/2021 | 135.95% | HC Wainwright & Co. | $80 → $81 | Maintains | Buy |
| 11/23/2020 | 133.03% | HC Wainwright & Co. | $82 → $80 | Maintains | Buy |
| 07/27/2020 | 138.86% | HC Wainwright & Co. | $96 → $82 | Maintains | Buy |
| 05/21/2020 | 179.64% | HC Wainwright & Co. | $94 → $96 | Reiterates | → Buy |
| 02/04/2020 | 173.81% | HC Wainwright & Co. | $110 → $94 | Maintains | Buy |
| 03/12/2018 | 261.2% | HC Wainwright & Co. | → $124 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/15/2022 | 57.3% | HC Wainwright & Co. | 73 美元 → 54 美元 | 維持 | 購買 |
| 01/31/2022 | 112.64% | HC Wainwright & Co. | 75 美元 → 73 美元 | 維持 | 購買 |
| 01/18/2022 | 118.47% | HC Wainwright & Co. | 82 美元 → 75 美元 | 維持 | 購買 |
| 2021 年 7 月 28 日 | 138.86% | HC Wainwright & Co. | 80 美元 → 82 美元 | 維持 | 購買 |
| 06/02/2021 | 133.03% | HC Wainwright & Co. | 81 美元 → 80 美元 | 維持 | 購買 |
| 2021 年 1 月 2 日 | 135.95% | HC Wainwright & Co. | 80 美元 → 81 美元 | 維持 | 購買 |
| 11/23/2020 | 133.03% | HC Wainwright & Co. | 82 美元 → 80 美元 | 維持 | 購買 |
| 07/27/2020 | 138.86% | HC Wainwright & Co. | 96 美元 → 82 美元 | 維持 | 購買 |
| 05/21/2020 | 179.64% | HC Wainwright & Co. | 94 美元 → 96 美元 | 重申 | → 購買 |
| 02/04/2020 | 173.81% | HC Wainwright & Co. | 110 美元 → 94 美元 | 維持 | 購買 |
| 03/12/2018 | 261.2% | HC Wainwright & Co. | → 124 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Taro Pharmaceutical Indus Questions & Answers
太郎製藥行業問題與解答
The latest price target for Taro Pharmaceutical Indus (NYSE: TARO) was reported by HC Wainwright & Co. on August 15, 2022. The analyst firm set a price target for $54.00 expecting TARO to rise to within 12 months (a possible 57.30% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2022年8月15日公佈了太郎製藥工業公司（紐約證券交易所代碼：TARO）的最新目標股價。該分析公司將目標股價設定爲54.00美元，預計TARO將在12個月內上漲至57.30％（可能上漲57.30％）。去年有3家分析公司公佈了評級。
The latest analyst rating for Taro Pharmaceutical Indus (NYSE: TARO) was provided by HC Wainwright & Co., and Taro Pharmaceutical Indus maintained their buy rating.
太郎製藥工業公司（紐約證券交易所代碼：TARO）的最新分析師評級由HC Wainwright & Co. 提供，太郎製藥工業維持買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Taro Pharmaceutical Indus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Taro Pharmaceutical Indus was filed on August 15, 2022 so you should expect the next rating to be made available sometime around August 15, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與太郎製藥工業的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。太郎藥業的最後一次評級是在2022年8月15日公佈的，因此您應該預計下一個評級將在2023年8月15日左右公佈。
While ratings are subjective and will change, the latest Taro Pharmaceutical Indus (TARO) rating was a maintained with a price target of $73.00 to $54.00. The current price Taro Pharmaceutical Indus (TARO) is trading at is $34.33, which is out of the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但太郎製藥工業公司（TARO）的最新評級維持不變，目標股價爲73.00美元至54.00美元。太郎製藥工業公司（TARO）目前的交易價格爲34.33美元，超出了分析師的預測區間。